P17.22.B SILMET TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE STAT3 INHIBITOR SILIBININ IN PREVENTING INTRACRANIAL RECURRENCE AFTER COMPLETE RESECTION OF A SINGLE BRAIN METASTASIS FROM NON-SMALL-CELL LUNG CANCER (NSCLC) OR BREAST CANCER

P17.22.B SILMET TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE STAT3 INHIBITOR SILIBININ IN PREVENTING INTRACRANIAL RECURRENCE AFTER COMPLETE RESECTION OF A SINGLE BRAIN METASTASIS FROM NON-SMALL-CELL LUNG CANCER (NSCLC) OR BREAST CANCER

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Vol. 26; no. Supplement_5; pp. v92 - v93
Main Authors: Pellerino, A, Pace, A, Angileri, F, Caffo, M, Gatti, M, Benicelli, E, Bertero, L, Ricci, A, Mangherini, L, Garbossa, D, Priego, N, Bosch-Barrera, J, Valiente, M, Rudà, R, Soffietti, R
Format: Journal Article
Language:English
Published: 17-10-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/noae144.309